1-2 of 2
Prasad R. K. Koduru
Close
Sort by
Journal Articles

Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts)

Krzysztof Mrózek, MD, PhD, Guido Marcucci, MD, Kati Maharry, MAS, Deedra Nicolet, MS, Heiko Becker, MD, Susan P. Whitman, PhD, Klaus H. Metzeler, MD, Sebastian Schwind, MD, Yue-Zhong Wu, MS, Jessica Kohlschmidt, PhD, Mark J. Pettenati, PhD, Prasad R. K. Koduru, PhD, Nyla A. Heerema, PhD, Annemarie W. Block, PhD, Shivanand R. Patil, PhD, Maria R. Baer, MD, Jonathan E. Kolitz, MD, Joseph O. Moore, MD, Andrew J. Carroll, PhD, Richard A. Larson, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2011) 118 (21): 414.
https://doi.org/10.1182/blood.V118.21.414.414
Published: 2011
Journal Articles

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461): Presented in part at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001, and published in abstract form. 59

Clinical Trials & Observations
John C. Byrd, Krzysztof Mrózek, Richard K. Dodge, Andrew J. Carroll, Colin G. Edwards, Diane C. Arthur, Mark J. Pettenati, Shivanand R. Patil, Kathleen W. Rao, Michael S. Watson, Prasad R. K. Koduru, Joseph O. Moore, Richard M. Stone, Robert J. Mayer, Eric J. Feldman, Frederick R. Davey, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (2002) 100 (13): 4325–4336.
https://doi.org/10.1182/blood-2002-03-0772
Published: 2002